2025
1360-P: CGM Sensors Improve the Estimation of Glycemic Outcomes in Newborns at Risk of Neonatal Hypoglycemia
MONTHE-DREZE C, CHERKERZIAN S, PRENDIN F, COBURN-SANDERSON A, ABDEL-RAHMAN R, DELFAVERO S, GALDERISI A, FACCHINETTI A, SEN S. 1360-P: CGM Sensors Improve the Estimation of Glycemic Outcomes in Newborns at Risk of Neonatal Hypoglycemia. Diabetes 2025, 74 DOI: 10.2337/db25-1360-p.Peer-Reviewed Original ResearchNeonatal hypoglycemiaContinuous glucose monitoringRisk of neonatal hypoglycemiaPoint-of-careGlycemic outcomesManagement of NHWeeks gestational ageImprove neurodevelopmental outcomesCapillary point-of-careCompared glycemic outcomesBlinded continuous glucose monitoringPoint-of-care methodWilcoxon Signed Rank TestMcNemar chi2Gestational ageContinuous glucose monitoring tracesNeurodevelopmental outcomesDetection rateAdverse neurodevelopmentNeonatesMedical managementBlood glucoseContinuous glucose monitoring inaccuracyRank testNewborns
2021
Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants
Galderisi A, Trevisanuto D, Russo C, Hall R, Bruschettini M. Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants. Cochrane Database Of Systematic Reviews 2021, 2021: cd013309. PMID: 34931697, PMCID: PMC8690212, DOI: 10.1002/14651858.cd013309.pub3.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsRisk of hypoglycaemiaUse of CGMContinuous glucose monitoringPreterm infantsIntermittent modalitiesRisk ratioEffects of CGMLong-term neurodevelopmental impairmentGlucose monitoringEfficacy of CGMCare Group (EPOC) criteriaPreterm infants 1Cochrane Effective PracticePrevention of morbidityClinical trials databasesLong-term outcomesConfidence intervalsPreterm infant mortalitySafety of CGMImprecision of estimatesFixed-effects modelAdverse neurodevelopmentGRADE approachNeurodevelopmental outcomesData collection
2020
Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants
Galderisi A, Bruschettini M, Russo C, Hall R, Trevisanuto D. Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants. Cochrane Database Of Systematic Reviews 2020, 12: cd013309. PMID: 33348448, PMCID: PMC8092644, DOI: 10.1002/14651858.cd013309.pub2.Peer-Reviewed Original ResearchConceptsPreterm infantsContinuous glucose monitoringGlycemic measuresRisk ratioIntermittent modalitiesLong-term neurodevelopmental impairmentGlucose monitoringCare Group (EPOC) criteriaCochrane Central RegisterCochrane Effective PracticePrevention of morbidityQuasi-randomized trialStandard search strategyClinical trials databasesLong-term outcomesPreterm infant mortalityAllied Health LiteratureUse of CGMImprecision of estimatesFixed-effects modelCochrane NeonatalAdverse neurodevelopmentCentral RegisterGRADE approachControlled Trials
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply